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Introduction: Lung diseases are an increasing global health burden affecting millions of
people worldwide. Only a few new inhaled medicines have reached the market in the last
30 years, in part due to foamy alveolar macrophage (FAM) responses observed in pre-
clinical rat studies. The induction mechanism and signaling pathways involved in the
development of highly vacuolated ‘foamy’ phenotype is not known. Furthermore, it has
not been determined if these observations are adaptive or adverse responses.
Aim: To determine if high content image analysis techniques can distinguish between
alveolar macrophage activation (LPS/IFN-g activated and IL-4 activated macrophages) and if
this could be applied to understanding the generation of ‘foamy’ macrophage phenotypes.
Methods: NR8383 rat alveolar macrophages were stimulated with a mix of cytokines
(LPS/IFN-g or IL-4) for 24 h. The cells were further exposed to FAM inducing-compounds
amiodarone and staurosporine. Following 24 h incubation, phagocytosis and lipid
accumulation were measured using flow cytometry and high content image analysis
techniques. The alveolar macrophages responses after exposure to cytokines were
assessed by evaluation: (i) cell surface and biochemical markers such as: nitric oxide
production, arginase-1 activity and MRC-1 receptor expression (ii) cellular morphology
(iii) cellular functionality (phagocytic activity and lipids accumulation).
Results: Macrophages activated with LPS/IFN-g showed distinct morphological
(increased vacuolation) features and functionality (increased lipidosis, decreased
phagocytic activity). Foamy macrophage phenotypes induced by amiodarone also
displayed characteristics of proinflammatory macrophages (significantly increased nitric
oxide production, increased vacuolation and lipidosis and decreased phagocytosis). In
contrast, staurosporine treatment resulted in increased NO production, as well as
arginase-1 activity.org September 2021 | Volume 12 | Article 6112801
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Frontiers in Immunology | www.frontiersin.Conclusion: High content image analysis was able to determine distinct differences in
morphology between non-activated and LPS/IFN-g activated macrophages,
characterized by increased vacuolation and lipidosis. When exposed to compounds
that induce a FAM phenotype, healthy non-activated macrophages displayed
proinflammatory (amiodarone) or pro-apoptotic (staurosporine) characteristics but these
responses were independent of a change in activation status. This technique could be
applied in early drug discovery safety assessment to identify immune responses earlier
and increase the understanding of alveolar macrophage responses to new molecules
challenge in development of new inhalation therapies, which in turn will enhance decision-
making in an early safety assessment of novel drug candidates.Keywords: alveolar macrophages, foamy alveolar macrophages, macrophage morphometrics, vacuolation,
cytokine activationINTRODUCTION
Alveolar macrophages are a heterogenous population of lung
immune cells involved in health and disease (1). Their main
function is provide tissue homeostasis by responding to
pathogens, clearance of surfactant and cell debris and to modulate
the adaptive immune response through antigen processing and
presentation (1). Additionally, they are involved in the resolution of
inflammation and tissue repair in the lungs (1). Alveolar
macrophages dynamically alter their phenotype and function
depending on their underlying microenvironment resulting in
shifts in their polarization state between classically (M1) and
alternatively (M2) activation states (2). M1-macrophages have the
role of effector cells in cellular immune responses. They are typically
activated by stimuli such as lipopolysaccharide (LPS) and interferon
gamma (IFN-g) which induce macrophages to produce large
amounts of pro-inflammatory cytokines such as tumor necrosis
factor alpha (TNF-a), interleukin (IL)-1-b, IL-6, IL-12 or IL-23 (3).
The antimicrobial function of M1-macrophages is linked to up-
regulation of enzymes, such as inducible nitric oxide synthase
(iNOS) which in turn generates nitric oxide (NO) (4). In contrast,
M2-macrophages promote tissue repair and remodeling and have
been reported to be involved in tumor progression.M2-macrophage
polarization is induced mainly (but not limited only to) by
interleukin 4 (IL-4) and results in the higher activity of arginase-1
enzyme, higher expression of MRC-1 receptor, as well as in
the production of high levels of IL-10 or IL-8 (3). Alveolar
macrophages alter their polarization state, from immune effector
cells to the wound-healing cells, in response to the surrounding
microenvironment. The plasticity of alveolar macrophages to alterhronic obstructive pulmonary disease;
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itric oxide synthase; K-F12, Kaighn’s
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org 2their polarization state is reported to be altered in certain
pathological conditions, [e.g. chronic obstructive pulmonary
disease (COPD)], which restricts their functional capabilities (5).
A foamy alveolar macrophage (FAM) is a term used to
describe a highly vacuolated phenotype of alveolar macrophages
viewed under light microscope (6, 7). This ‘foamy’ phenotype is
commonly observed during non-clinical studies of newmedicines
for inhalation and is likely to represent a spectrum of adverse and
adaptive responses (6). It is not well understood whether FAM
responses are adverse or adaptive, and there are no acceptance
criteria to differentiate between various types of FAM phenotypes.
Furthermore, the induction mechanism and signaling pathways
involved in the development of a highly vacuolated phenotype has
not been explored in detail. FAM can be induced via different
pharmacological or non-pharmacological mechanisms (8).
Currently, there are two established distinct mechanisms which
observe development of a FAM phenotype, namely
phospholipidosis or apoptosis, which can be induced either by
amiodarone or staurosporine respectively (9, 10). Whilst the
cellular and morphometric status of these FAM have been
reported previously (9), no studies have investigated the role
that macrophage activation status may play in FAM generation
and response. This role may be of dual nature; pre-existing M1
or M2 populations of macrophages may contribute to
FAM responses and/or FAM inducers may induce M1 or
M2 polarization.
The overall aim of this study was to evaluate if high content
image analysis methodologies which assess morphology and cell
health within early safety assessment could be used to ascertain
macrophage polarization/activation and provide an earlier
indication of potential immune responses and/or foamy
alveolar macrophage induction in the drug discovery process.
In order to achieve this, in vitro rat alveolar macrophages were
profiled (including polarization status, phagocytosis capability
and lipid accumulation) in response to established foamy
macrophage inducers, amiodarone and staurosporine. We
hypothesize that specific FAM phenotypes may be associated
with differential polarization status which may affect the
resolution of the FAM phenotype and facilitate early decision-
making in drug discovery process.September 2021 | Volume 12 | Article 611280
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Materials
Amiodarone hydrochloride 5 µM (cat#A8423, Sigma Aldrich,
Pool, Dorset, UK) and staurosporine 0.1 µM (cat#S4400, Sigma
Aldrich, Pool, Dorset, UK) were used to induce foamy
macrophage phenotypes without significantly affecting the cell
count and viability. Lipopolysaccharide (LPS, cat#L2630, Sigma
Aldrich, Dorset, UK), recombinant rat interferon gamma (IFN-g,
cat#550072), and recombinant rat interleukin 4 (IL-4, cat#555107)
were purchased from BD Biosciences, (Wokingham, Berkshire,
UK), while recombinant rat interleukin 13 (IL-13, cat#CB243IL13)
was purchased from PAN-Biotech (Wimborne, Dorset, UK). LPS
and interleukins were used to activate macrophages to M1 or M2
polarization state.
Cell Culture
The NR8383 cell line was chosen for this study as it provides a
homogenous source of highly responsive alveolar macrophages
(11, 12). Moreover, it is an established and well characterized
alveolar macrophage cell line with appropriate culture
characteristics and suitable as comparator cell line for in vivo
alveolar macrophage responses observed in the Sprague-Dawley
rat model (11, 12). The cell line was obtained from LGC
Standards (cat#AgC11x3A, Teddington, Middlesex, UK) and
used between passage numbers 2 and 20 from purchase.
NR8383 cells were maintained in a humidified atmosphere at
37°C with 5% v/v CO2. Culture medium consisted of Kaighn’s
modified Ham’s F12 medium (K-F12; cat# 21127030, Gibco, Life
Technologies, UK) supplemented with 15% v/v heat-inactivated
fetal bovine serum (FBS; cat#F7524, Sigma Aldrich, Dorset, UK),
with 100 IU/ml penicillin-100 µg/ml streptomycin solution
(cat#P4333, Sigma Aldrich, Dorset, UK) and 2 mM L-
glutamine (cat#G7513, Sigma Aldrich, Dorset, UK). Cells were




NR8383 cells were seeded onto 96-well plates (cat#7340023, VWR
International Ltd., Lutterworth, Leicestershire, UK) or 24-well plates
(cat#7340020, VWR International Ltd., Lutterworth, Leicestershire,
UK) at an optimal density of 0.5 x 105 cells/well or 2.4 x 105 cells/
well respectively and cultured for 24 h. Three dosing schemes
representing three in vitro models were explored. Model M0
represented healthy, non-activated macrophages to evaluate cell
activation and function following 24 h exposure to amiodarone
(5 µM) and staurosporine (0.1 µM). Model M(LPS+/IFN-g+)
represented proinflammatory activated macrophages (often found
in asthma or COPD). M(LPS+/IFN-g+) macrophage responses to
the FAM inducers were evaluated. To this purpose, NR8383 were
exposed for 24 h to100 ng/mL LPS and 20 ng/mL IFN -g prior to
exposure to amiodarone (5 µM) and staurosporine (0.1 µM) for an
additional 24 h. Model M(IL-4+) represented IL-4-stimulated
macrophages (often found in pulmonary fibrosis or lung tumor).
M(IL-4+)-activated macrophage responses to the FAM inducers
were evaluated. To this purpose, NR8383 were exposed for 24 h toFrontiers in Immunology | www.frontiersin.org 325 ng/mL IL-4 with or without 10 ng/mL IL-13 prior to exposure to
amiodarone (5 µM) and staurosporine (0.1 µM) for an additional 24
h. At the end of the treatment period cells were evaluated for nitric
oxide production, arginase-1 activity and MRC-1 receptor
expression, phagocytosis and phospholipids accumulation.Cell Vacuolation and Quantification
of Lipids
Fluorescence staining and imaging were performed as described
previously by Hoffman et al. to determine the cellular lipid
content and to assess macrophage morphology (9). Briefly,
macrophages were incubated simultaneously with the tested
compound and HCS LipidTox Phospholipid Red dye
(cat#H34351, Invitrogen, Renfrewshire, UK) diluted 1:1000
(according to the manufacturer’s protocol) for 24 h. After the
desired compound exposure time, the cells were fixed with 3.7%
w/v paraformaldehyde (PFA; cat#P6148, Sigma Aldrich, Pool,
Dorset, UK) containing Hoechst 33342 (10 µg/mL; cat#H3570,
Invitrogen, Renfrewshire, UK) for 20 min, followed by one wash
step with 100 µl phosphate buffered saline (PBS; cat#P4417,
Sigma Aldrich, Pool, Dorset, UK). The cells were then incubated
with HCS LipidTox Neutral Lipid Green dye (cat#H34475,
Invitrogen, Renfrewshire, UK) diluted 1:1000 (according to the
manufacturer’s protocol) and Cell Mask Deep Red (cat#H32721,
Invitrogen, Renfrewshire, UK) diluted 1:1000 (according to the
manufacturer’s protocol) for 30 min at room temperature for
assessment of neutral lipid accumulation and morphometric
characterization, respectively. The cells from the assay were
stored in the dark at 4°C before sample acquisition.
Cell health (mitochondrial activity and cell membrane
integrity) was assessed as outlined previously by Hoffman
et al., 2017 (9). In brief, cells were either incubated with
amiodarone or staurosporine. Following 24 h incubation, cells
were stained with a dye cocktail containing Hoechst 33342 (10
µg/mL), MitoTracker Red (300 nM; cat#M7512, Invitrogen,
Renfrewshire, UK) and Image-It-Dead Green (25 nM;
cat#I10291, Invitrogen, Renfrewshire, UK) for 30 min. Cells
were washed once with PBS and fixed with 3.7% PFA for 15
min. Cells were washed once before imaging.
Images were captured using the InCell Analyser 6500HS (GE
Healthcare, Little Chalfont, Bucks, UK) with a 40x objective in
standard 2D imaging mode with an exposure time of 0.1 s. A high
content image analysis protocol developed previously by Hoffman
et al. was employed (9). Briefly, InCell Developer Toolbox v 1.9.2,
Level 3 software (GE Healthcare, Little Chalfont, Bucks, UK) was
used to quantify parameters including: cell count, average cellular
and nuclear area, average number of vacuoles per cell, average area
of a single vacuole, average area of all vacuoles, percent of cell
occupied by all vacuoles and intracellular lipid content. Nucleated
cells were identified based on Hoechst 33342 staining. Cell Mask
DeepReddyewasused tohighlight the cytoplasmic regionswith the
cells, while negative staining with the dye was used to segment
vacuoles within cells. The intercellular phospholipid and neutral
lipid accumulation were quantified and reported as fluorescence
intensity values of HCS LipidTox Phospholipid Red and HCS
LipidTox Neutral Lipid Green stains.September 2021 | Volume 12 | Article 611280
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The supernatant was collected, and nitric acid production was
determined in the form of total nitrites using the Greiss Reagent
System (cat#G2930, Promega, Southampton, Hampshire, UK)
according to the manufacturer’s protocol. Briefly, 50 µl of
supernatant was mixed with 50 µl of sulfanilamide solution
(1% w/v sulfanilamide in 5% w/w phosphoric acid). Following
a 10 min incubation, 50 µl of NED solution (0.1% w/v N-1-
napthylethylenediamine dihydrochloride in water) was added
and incubated for a further 10 min. The absorbance was
measured at 540 nm, and the concentration of nitrite was
calculated from a standard curve of sodium nitrite.
Arginase Quantification
Arginase activity of the NR8383 macrophage lysates was
measured by a colorimetric Arginase Activity Assay Kit
(cat#MAK112, Sigma Aldrich, Pool, Dorset, UK) according to
the manufacturer protocol. Briefly, substrate buffer (containing
MnCl2 and L-arginine) was added to the lysates and incubated
for 2 h at 37°C. The reaction was stopped by adding the urea
solution for 1 h at room temperature. The urea generated by
arginase was quantified by absorbance measurement at 430 nm.
One unit of arginase activity is defined as the amount of Mn2+
activated enzyme that produces 1 mmol of ornithine/min at 37°C.
MRC-1 Receptor Expression
MRC-1 receptor expression was quantified using flow cytometry.
At the end of treatment period, cells were harvested, blocked
with 10% goat serum (cat#ab7481, Abcam, Cambridgeshire, UK)
and incubated with MRC-1 polyclonal antibody (cat#PA5-
114370, Invitrogen, Renfrewshire, UK) for 30 min at room
temperature. The cells were then labelled with Goat anti-
Rabbit IgG (H+L) cross-absorbed secondary antibody, FITC
(cat#F-2765, Invitrogen, Renfrewshire, UK) for 30 min at room
temperature, in the dark. A representative 10,000 cells were
acquired and analyzed using the Guava EasyCyte system
(Guava EasyCyte 8HT, Millipore, UK). Cells were identified
from free particles and cellular debris by their forward and
side scatter. MRC-1 surface receptor expression was quantified
by processing the green fluorescence (Ex/Em: 505/515) of cells
and comparison with non-stimulated control.
Phagocytosis
To determine phagocytic activity, NR8383 cells were incubated
with 1.0 µm microspheres at a ratio of 1:30 (cells: particles).
Briefly, at the end of treatment period, the media containing 1.0
µm Carboxylate-Modified Microspheres (cat#F8823, Invitrogen,
ThermoFisher, UK) was added for 2 h and cells were incubated at
normal culture conditions. Cells were harvested by gentle
scraping and the cell fluorescence (Ex/Em: 505/515) was
measured using the Guava EasyCyte system (Guava EasyCyte
8HT, Millipore, UK). Cells were identified from free particles and
cellular debris by their forward and side scatter. Phagocytic
activity was assessed by processing the green fluorescence
(525 ± 30 nm) of cells and comparison with untreated control.
At least 5000 cells were counted for each sample.Frontiers in Immunology | www.frontiersin.org 4Statistical Analysis
All experiments were repeated independently at least three times,
with n=3 wells per experiment, and approximately 1000 – 2000
individual cells measured per well in the morphology study. Data
from repeated experiments were assessed using the Shapiro-Wilk
test for normality and found to fit a normal (Gaussian)
distribution). All reported parameters were normalized to the
number of viable cells in a sample. Statistical comparisons were
made using a one-way ANOVA analysis with Bonferroni’s
multiple comparison post-hoc test. Values of p < 0.05 were
considered to be statistically significant and denoted as follows:
*, p < 0.05; **, p < 0.01; and ***, p < 0.001.RESULTS
Confirmation of Macrophage Activation
Macrophage activation was determined using a combination of
cell surface and biochemical markers (4, 13). LPS/IFN-g-
activated macrophages [M(LPS+/IFN-g+)] produced a
significantly higher concentration of nitric oxide (NO) (p <
0.01) in comparison with non-activated macrophages which
produced very low levels of NO (Figure 1A). Increased NO-
production by LPS/IFN-g-stimulated macrophages suggests
classically (M1) activation. However, these findings should be
supported by assessment of additional M1 polarization markers.
The upregulation in arginase-1 (Arg-1) activity and MRC-1
receptor expression are considered as established markers for
alternative (M2) activation (14). In this study NR8383 activation
with IL-4 did not generate increased arginase activity
(Figure 1B) suggesting that IL-4 was unlikely to have activated
NR8383 cells. This finding was further supported by a non-
significant increase in MRC-1 receptor expression (Figure 1C).
Moreover, stimulation with a combination of IL-4 and IL-13 did
not result in a distinct activation status.
Distinct Morphological Features Identified
for M(LPS+/IFN-g+) Macrophages
Macrophages were activated using a mix of LPS and IFN-g, or IL-4,
respectively. The cell morphology (nuclear and cellular area,
number and size of vacuoles, area of a cell occupied by vacuoles)
was assessed 24 h after activation (Figure 2). It was observed that
LPS/IFN-g activated cells displayed distinct morphological changes
(p < 0.001) when compared to untreated cells. M(LPS+/IFN-g+)
macrophages displayed significantly increased (p < 0.01) total cell
area from 226 (± 20) µm2 (M0) to 290 (± 51) µm2 [M(LPS+/IFN-
g+)] and significantly decreased (p < 0.01) nuclear area from 75
(± 5) µm2 (M0) to 65 (± 8) µm2 [M(LPS+/IFN-g+)] when compared
to non-polarized cells (Figures 2A, B). Moreover, M(LPS+/IFN-g+)
cells contained on average 6 (± 2)more vacuoles (p < 0.001), and the
average area these vacuoles occupied increased from 2.16 (± 0.2)
µm2 (M0) to 2.4 (± 0.2) µm2 [M(LPS+/IFN-g+)] (p < 0.001)
(Figures 2C, D). The total area of the cell occupied by vacuoles
was 40 (± 9.5) µm2 in M(LPS+/IFN-g+)-activated macrophages
compared with only 20 (± 3.3) µm2 in non-polarized cells (p <
0.001) (Figure 2F). The M(LPS+/IFN-g+) cell area occupied bySeptember 2021 | Volume 12 | Article 611280
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(M0) to 11.7 (± 1.2) % (M(LPS+/IFN-g+)) (Figure 2E). None of the
morphological features assessed for IL-4 treated cells were
significantly different (p > 0.05) from non-polarized macrophages
confirming that NR8383 activation to an M2 phenotype with IL-4
alone was likely to be unsuccessful. Percentage of alveolar
macrophage population displaying increased/decreased features
were calculated and presented as a heatmap in supplementary
material (Supplementary Figure 2).
M(LPS+/IFN-g+) activation phenotype was also reflected in
NR8383 functionality (Figure 3). The percentage of cells that
remained adhered to the well plate was calculated from the
number of nucleated, polarized cells as a fraction of the adhered
cells in the non-polarized (M0) control population. The fraction of
adherent cells decreased to 45 (± 9) % of the non-polarized control
(p < 0.001) (Figure 3A). There was a significant decrease (p < 0.01)
observed in the phagocytic activity of macrophages with the
phagocytic cell population decreasing from 51 (± 5.9) % (M0) to
41 (± 7.6) % (M(LPS+/IFN-g+)) (Figure 3B). M(LPS+/IFN-g+) cells
had significantly accumulated phospholipids (1.5-fold increase; p <
0.001) and neutral lipids (2.7-fold increase; p < 0.001) in comparisonFrontiers in Immunology | www.frontiersin.org 5to non-polarizedM0 cells. Consistent with the finding of unchanged
morphological features in NR8383 macrophages, no changes in
macrophage function were observed following stimulation with
IL-4.
Amiodarone and Staurosporine Increase
NO Production by Macrophages
The ability of macrophages to undergo LPS/IFN-g-activation and
respond to a drug challenge was assessed. Nitric oxide (NO)
production was quantified. Significant differences (p < 0.01 and p
< 0.001) in NO production were observed dependent on whether
the cells were activated with LPS/IFN-g or not prior to a drug
challenge (Figure 4).
The production of NO in untreated but activated macrophages
M(LPS+/IFN-g+) was significantly (p < 0.01) higher when
compared to non-activated control cells (M0). After challenging
both macrophage groups (M0 and M(LPS+/IFN-g+)) with
amiodarone, there was no significant (p > 0.05) difference in NO
production between activated and non-activated macrophages.
Whilst staurosporine treatment resulted in a significant (p < 0.01)
increase in NO production by macrophages which wereA
C
B
FIGURE 1 | NR8383 rat macrophage activation status after stimulation with (A) LPS and IFN-g, (B) IL-4 or (C) IL-4 or IL-4/IL-13. Data are normalized to
cell count and presented as mean values ± SEM of three separate experiments. Statistical comparisons are made using a one-way ANOVA analysis with
Bonferroni’s multiple comparison post-hoc test. Results are compared to non-polarized control (M0) and statistical significance is marked as follows: * indicates
p < 0.01. (C) Representative fluorescent dot (quadrants) plots showing percentage of cells expressing MRC-1 surface receptor.September 2021 | Volume 12 | Article 611280
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suggest that M(LPS+/IFN-g+)-polarized cells are more sensitive to
exposure of apoptotic agents such as staurosporine.
Staurosporine Increases Arginase
Activity but Not MRC-1 Surface
Receptor Expression
Arginase activity and MRC-1 surface receptor expression were
measured as markers for alternatively activated macrophages
(Figure 5). Although the NR8383 polarization to an M2
phenotype was not reflected in arginase-1 activity nor MRC-1
expression, a significant (p < 0.001) increase of arginase-1 activityFrontiers in Immunology | www.frontiersin.org 6was observed after exposure to 0.1 µM staurosporine. M0 and IL-4
treated macrophages stimulated with staurosporine showed a
significant increase in arginase activity when compared to non-
polarized cells (p < 0.001) (Figure 5A), whilst there was no
significant increase (p > 0.05) in surface expression of the MRC-1
receptor (Figure 5B).
Morphological Changes of M(LPS+/IFN-g+)-
Macrophages Are Not Modulated by FAMs
Inducers
M0 and M(LPS+/IFN-g+) macrophages were exposed to FAM




FIGURE 2 | Morphological characteristic of non-activated, M(LPS+/IFN-g+) or M(IL-4+) activated NR8383 rat macrophages. Nuclear area (A), cellular area
(B), number vacuoles per cell (C), average area of a single vacuole (D), cellular area occupied by all vacuoles (E) and total area of all vacuoles per cell (F) were
quantified in non-activated macrophages (M0), activated with 100 ng/mL LPS and 20 ng/mL IFN-g [M(LPS+/IFN-g+)] or activated with 30 ng/mL IL-4 [M(IL-4+)].
Data are presented as mean values ± SEM of three separate experiments. Statistical comparisons are made using a one-way ANOVA analysis with Bonferroni’s
multiple comparison post-hoc test. Results are compared to non-polarized control (M0); *** indicates p < 0.001.September 2021 | Volume 12 | Article 611280
Hoffman et al. Foamy Alveolar Macrophage (FAM) Activation24 h incubation macrophage morphometrics was assessed
(Figure 6). There were no significant changes (p > 0.05)
observed in the non-polarized macrophage population (M0)
regardless of the drug treatment. Noteworthy changes were
observed in untreated M(LPS+/IFN-g+)-polarized cellsFrontiers in Immunology | www.frontiersin.org 7confirming their M(LPS+/IFN-g+)-distinct appearance
presented above in Figure 2. Additional treatment with FAM
inducers did not change their morphological characteristics, with
an exception of staurosporine stimulation, which significantly
(p < 0.05 and p < 0.01) affected only two features: average area of
a vacuole (Figure 6D) and total area of vacuoles (Figure 6F).
Additionally, percentage of macrophage population displaying
increased/decreased features were calculated in presented as
macrophage response profiles in supplementary material
(Supplementary Figure 3).
Phagocytic Capability of NR8383 Is Not
Affected by FAM-Inducers
The phagocytic activity of M(LPS+/IFN-g+) activated and/or
foamy-induced macrophages was evaluated by incubation of the
NR8383 cells with 1 µm microspheres for 2 h (Figure 7). The
results were compared with non-polarized macrophages (M0).
Neither amiodarone nor staurosporine affected phagocytic
capability of non-polarized (M0) macrophages. M(LPS+/
IFN-g+) cells showed fewer beads were taken up into the cells,
suggesting a lower phagocytic ability than non-activated M0 cells
(p < 0.01). Treatment with FAM-inducers did not change
significantly phagocytic activity within already M(LPS+/
IFN-g+) activated cells (p > 0.05).A
C D
B
FIGURE 3 | Functional characteristic of non-activated, M(LPS+/IFN-g+) or M(IL-4+) activated NR8383 rat macrophages. Cell count (A), phagocytic activity
(B), cellular phospholipid (C) and cellular neutral lipid content (D) were quantified in non-activated macrophages (M0), activated with 100 ng/ml LPS and 20 ng/ml
IFN-g [M(LPS+/IFN-g+)] or activated with 30 ng/ml IL-4 [M(IL-4+)]. Data are normalized to cell count and presented as mean values ± SEM of three separate
experiments. Statistical comparisons are made using a one-way ANOVA analysis with Bonferroni’s multiple comparison post-hoc test. Results are compared to
non-polarized control (M0); ** indicate p < 0.01, *** indicate p < 0.001.FIGURE 4 | Effect on NO production in non-activated (M0) and LPS/IFN-g
activated NR8383 rat macrophages after 24 h exposure to 5 µM
amiodarone (orange bars) and 0.1 µM staurosporine (purple bars). Data are
normalized to cell count and presented as mean values ± SEM of four
separate experiments. Statistical comparisons are made using a one-way
ANOVA analysis with Bonferroni’s multiple comparison post-hoc test.
Results are compared to non-polarized control (M0); **indicate p < 0.01
and *** indicates p < 0.001.September 2021 | Volume 12 | Article 611280
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Displayed Increased Lipid Content
Lipid content was assessed in non-activated and activated
macrophages after a drug challenge (Figure 8). Amiodarone-
treated cells displayed 1.5-fold (p < 0.001) higher phospholipid
accumulation in non-polarized cells, and 3.8 times (p <0.001)
higher phospholipid content when cells where pre-activated to
an M(LPS+/IFN-g+) phenotype (Figure 8A). Neutral lipid
content was significantly (p < 0.001) increased when cells were
activated to M1 polarization prior to a drug treatment. There was
no additional neutral lipid accumulation induced by amiodarone
nor staurosporine when cells were M(LPS+/IFN-g+) activated
prior to a drug challenge (Figure 8B).DISCUSSION
Macrophages are characterized by remarkable plasticity that can
transform from one phenotype to another (2). These immuneFrontiers in Immunology | www.frontiersin.org 8defense cells show various polarization states depending on
micro-environmental stimuli and signals, and can be classified
as classically activated (M1) or alternatively activated (M2)
macrophages (2). M1-macrophages have anti-microbial and
anti- tumor activities, mediate tissue damage and initiate
inflammatory responses. They contribute to the host defense
by generating reactive nitric oxide (NO) and releasing
proinflammatory cytokines and chemokines such as IL-1b, IL-
12, IL-23, CCL-2 and TNF-a. The generation of M1
macrophages is stimulated by such potent inducers as LPS and
IFN-g (1, 5, 14). M2-macrophages are implicated to play a vital
role in immunosuppression, would healing or tumor progression
(15). They can be activated by IL-4, IL-13, TGF-b and IL-10.
Depending upon the specific stimuli, M2 macrophages can be
further divided into M2a, M2b, M2c and M2d (16). However,
there are no validated markers to distinguish between these
subtypes. Phenotypically M1 macrophages present increased
iNOS expression, while M2 macrophages are characterized by
increased activity of Arg-1 enzyme, which in turn promotesA
B
FIGURE 5 | Effect on arginase activity and MRC-1 receptor expression in M0-non-activated and IL-4 activated NR8383 rat macrophages after 24 h exposure to 5
µM amiodarone and 0.1 µM staurosporine. (A) Effect on arginase activity. Data are normalized to cell count and presented as mean values ± SEM of three separate
experiments. Statistical comparisons are made using a one-way ANOVA analysis with Bonferroni’s multiple comparison post-hoc test. Results are compared to non-
polarized control (M0); *** indicates p < 0.001. (B) Representative fluorescent dot (quadrants) plots showing percentage of cells expressing MRC-1 surface receptor.September 2021 | Volume 12 | Article 611280
Hoffman et al. Foamy Alveolar Macrophage (FAM) Activationcollagen synthesis by making the amino acid proline available for
fibroblasts (17). Therefore, NO production and arginase activity
were chosen as M1 and M2 macrophage markers in this study,
respectively, alongside specific cell surface receptor expression in
order to confirm macrophage polarization status. Macrophage
polarization has been widely investigated previously with an
attempt to explain the alveolar macrophage activation status in
various diseases e.g. COPD, lung cancer (13, 18–20). However,
there are no studies to date investigating FAM responses in the
context of macrophage activation. The appearance of foamy
alveolar macrophages during rat in vivo inhalation therapy
development studies is common and it is not certain is these
changes observed in rats and other animal species indicate
adversity to human lung health (6, 7). We have previously
described FAM morphometry in different species andFrontiers in Immunology | www.frontiersin.org 9macrophage responses to amiodarone and/or staurosporine (8,
10). This study investigated the functionality of alveolar
macrophages when polarized, and when induced to foamy
phenotype providing new insights to understanding alveolar
macrophage biology and their role in responding to xenobiotics.
First, we examined macrophage activation by quantification
of NO cellular production and arginase-1 activity as markers for
M1 or M2 activation, respectively. In this study, NR8383 cells
were activated with a cytokine mix (LPS/IFN-g) suggesting M1
polarization (Figure 1A). However, these results should be
further confirmed by additional M1-markers evaluation.
Therefore, in this study, LPS/IFN-g-activated cells were
referred as M(LPS+/IFN-g+). While M2 activation was not
achieved, with no increase in arginase-1 activity observed or




FIGURE 6 | Morphological characteristic of M0 and LPS+/IFN-g+ activated NR8383 rat macrophages after 24 h exposure to 5 µM amiodarone (orange bars) and
0.1 µM staurosporine (purple bars). Nuclear area (A), cellular area (B), number vacuoles per cell (C), average area of a single vacuole (D), cellular area occupied by
all vacuoles (E) and total area of all vacuoles per cell (F) were quantified in non-polarized macrophages (M0) and LPS+/IFN-g activated [M(LPS+/IFN-g+)] cells
followed by 24 h activation with FAM. Data are normalized to number of cells and presented as mean values ± SEM of three separate experiments. Statistical
comparisons are made using a one-way ANOVA analysis with Bonferroni’s multiple comparison post-hoc test. Results are compared to non-polarized control (M0)
(except otherwise indicated) and statistical significance is marked as follows: * indicate p < 0.05, ** indicate p < 0.01, *** indicate p < 0.001.September 2021 | Volume 12 | Article 611280
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phenotype in various types of macrophages (e.g. monocyte-
derived macrophages) (5), IL-4 was not sufficient for
macrophage polarization of alveolar macrophages NR8383. To
confirm these findings, MRC-1 receptor expression wasFrontiers in Immunology | www.frontiersin.org 10quantified showing insignificant upregulation of this M2
polarization marker (Figure 1C). Furthermore, stimulation
with both IL-4 and IL-13 also failed to polarize NR8383 to M2
status. Overall, in this study NR8383 rat alveolar macrophages
stimulated with IL-4 or a mixture of IL-4 and IL-13 did not show
a distinct M2 polarization.
Second, morphological features in the non-activated (model
M0) and activated [model M(LPS+/IFN-g+) or model M(IL-4+)]
macrophages were characterized. M(LPS+/IFN-g+) activated
macrophages displayed distinct morphology (Figure 2). The
cell area of macrophages activated with LPS/IFN-g was
increased, whilst the nuclear area was decreased when both
parameters were compared with M0 cells. M(LPS+/IFN-g+)
cells showed an increased vacuolation pattern which was
reflected in the increase of all vacuolation metrics (vacuoles
number, average and total area of vacuoles, cellular area
occupied by vacuoles). Distinct morphological features of M
(LPS+/IFN-g+) and M(IL-4+) macrophages have been
recognized previously by Bertani et al. (21), where based only
on qualitative fluorescence microscopy images, M(LPS+/IFN-g+)
macrophages were described to be of a spindle shape, while M
(IL-4+) activated cells were more spread and very often
multinucleated (21). However, no detailed morphological
features have been measured. Our study for the first time
provides a detailed quantification of M(LPS+/IFN-g+) activated
macrophage morphology (Figures 2, 3 and Supplementary
Figure 2). Morphological analysis of cells is increasingly
important as it aids examination of cell behavior. For example,
recent developments of cell physiology and cell image analysis
have begun to establish correlations between cell geometry and
the activation of specific pathways in some cancers (22).
Likewise, changes in alveolar macrophage physiology can be
reflected in macrophage morphology, as demonstrated in this
study for M(LPS+/IFN-g+) activated cells.
Observed differences in M(LPS+/IFN-g+) morphology were
also reflected in cell function (Figure 3). Phagocytosis is a
mechanism by which macrophages engulf and eliminate
foreign particles. In this study, M(LPS+/IFN-g+) macrophage
activation affected their phagocytic capability. It has been
reported previously that IFN-g stimulation down-regulated
phagocytosis (14). In line with that report, suppressed
phagocytic activity was observed in M(LPS+/IFN-g+) activated
cells compared to M0. The accumulation of lipids (lipidosis) in
macrophages is typically linked with macrophage dysfunction
(23). However, the correlation between alveolar macrophage
lipidosis and polarization has not previously been investigated.
This study reports for the first time that, in addition to the
characteristic increase in NO production, M(LPS+/IFN-g+)
cells had accumulated a pool of significantly more
phospholipids and neutral lipids than non-activated control.
This finding supports previously reported observations linking
lipid-rich macrophages with the secretion of multiple pro-
inflammatory mediators (23).
In contrast to the M(LPS+/IFN-g+) distinct phenotypic
changes, attempts to achieve M(IL-4)-activation did not affect
cell morphology nor functionality, which confirms the failure ofA
B
FIGURE 8 | Phospholipid (A) and neutral lipid (B) content in M0-non-
activated, LPS/IFN-g and IL-4 activated NR8383 rat macrophages after 24 h
exposure to 5 µM amiodarone (orange bars) and 0.1 µM staurosporine
(purple bars). Data are normalized to cell count and presented as mean
values ± SEM of three separate experiments. Statistical comparisons are
made using a one-way ANOVA analysis with Bonferroni’s multiple comparison
post-hoc test. Results are compared to non-polarized control (M0);
*** indicates p < 0.001.FIGURE 7 | Phagocytic activity in M0-non-activated, LPS/IFN-g or IL-4
activated NR8383 rat macrophages after 24 h exposure to 5 µM amiodarone
(orange bars) and 0.1 µM staurosporine (purple bars). Data are expressed as
a percentage of the phagocytic activity of non-polarized untreated NR8383
cells. Data represent the mean values ± SEM of three separate experiments.
Statistical comparisons are made using a one-way ANOVA analysis with
Bonferroni’s multiple comparison post-hoc test. Results are compared to
non-polarized control (M0); ** indicate p < 0.01, *** indicates p < 0.001.September 2021 | Volume 12 | Article 611280
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macrophages being multinucleated in response to stimulation
with IL-4, as it has been described previously by Bertani et al.
(21). This discrepancy in findings may be due to interspecies
differences, highlighting variances in both polarization which
further questions the relevance of animal models of
inflammation. Furthermore, the source of macrophages may be
an important consideration. Bertani et al. investigated
macrophages derived from blood monocytes, while this study
is focused specifically on alveolar macrophages. It has been
demonstrated that populations of tissue-specific macrophages
derived from yolk sac or fetal liver possess different
functionalities to monocyte-derived macrophages from
peripheral blood (13). Therefore, alveolar macrophage
characterization and responses may be different from
circulating macrophages (13).
Thirdly, we investigated macrophage activation in the
presence of compounds that induce a FAM phenotype.
Amiodarone and staurosporine were used as model drugs to
induce FAM phenotype in vitro (10). Both compounds at the
selected concentrations induced morphological changes but did
not significantly affect (p < 0.05) cell viability (9)
(Supplementary Figure 1A) and cell health assessed by
mitochondrial activity and cell membrane permeability
(Supplementary Figure 1B). Amiodarone is an established
inducer of phospholipidosis and has been shown to induce a
very distinct foamy macrophage phenotype typically
characterized by a coarsely vacuolated appearance (24, 25).
Staurosporine is pro-apoptotic agent reported previously to
induce morphological foamy-like changes in a cell (26, 27).
Detailed individual macrophage responses characterized
including cell viability, morphology and lipid content
parameters have been described previously by Hoffman et al.
(9, 10). The current study evaluated how these parameters are
altered in the context of macrophage polarization and
explored how pharmacological stimuli influence polarization
status. Resident alveolar macrophages present in healthy
lungs reside in the airways predominantly as a non-
polarized population showing neither M1 nor M2
polarization (13). Therefore, the model M0 represents
healthy alveolar macrophages, where NR8383 were only
exposed to the foamy inducers, without pre-activation with
cytokines. Patel et al. showed in the recent publication that
amiodarone induced phospholipidosis in rat studies
accompanied by increased inflammation (24). The current
study confirms a similar effect of amiodarone in vitro.
Increased phospholipid accumulation was observed, as well
as increased NO production suggesting that macrophages are
in proinflammatory state.
In contrast, staurosporine increased arginase activity while
failing to induce accumulation of neutral lipids or phospholipids
in M0 cells and appeared to direct a cell towards an anti-
inflammatory and would healing phenotype. This finding is in
agreement with established cell responses to staurosporine (26).
In additional to being a potent proapoptotic agent, staurosporine
also has antimicrobial, antifungal and immunosuppressiveFrontiers in Immunology | www.frontiersin.org 11activity when dosed in sublethal concentrations (26).
Furthermore, treatment with FAM-inducers, such as
amiodarone and staurosporine, in sub-toxic doses did not
modulate phagocytic activity, suggesting that although
morphological changes in the cell occurred, these did not alter
phagocytic processes. This important finding shows that
macrophages preserve functionality even when displaying
foamy morphology. The morphological observations reported
in this study are easily defined and quantified using high content
image analysis and have potential to provide an earlier and more
sensitive indication of cell adaptation/adversity than biochemical
and functional alternations. While adverse macrophage
responses are typically linked with functional impairment (28,
29), morphological changes have the potential to determine
whether a response is truly adverse or adaptive informing
better go-no-go decision making in early pre-clinical
safety assessment.
Finally, we evaluated FAM responses in a diseased in vitro
model. Model M(LPS+/IFN-g+) represented macrophages of
inflamed lungs (e.g. in such diseases as asthma, COPD). M
(LPS+/IFN-g+) cells are the major effector macrophages in
non-allergic asthma (30) and have been linked with the
pathology of severe asthma and COPD (13, 17). NR8383 were
activated with LPS and IFN-g to M(LPS+/IFN-g+) before drug
exposure. We presented above that M(LPS+/IFN-g+)-
macrophages display a unique morphology. M(LPS+/IFN-g+)-
macrophages treated with amiodarone showed an elevated
production of NO (one of M1-polarization marker), enhanced
ability to accumulate phospholipids and reduced phagocytic
capability. Staurosporine also increased NO production in M
(LPS+/IFN-g+) cells, as well as inducing increased production of
lipids, not observed when M0 cells were treated with
staurosporine. Overall, both FAM inducer compounds
increased proinflammatory properties of macrophages in an
already inflamed microenvironment.
It has been recognized that M1/M2 paradigm with its
polarized extremes is oversimplification. However, these types
of in vitro studies may provide a useful guide for studying
macrophage biology in vivo. Likewise, macrophages placed in
the culture may no longer resemble these which exist in vivo.
Further studies should investigate how to assess macrophage
phenotype in vitro more accurately.
In conclusion, we showed that M(LPS+/IFN-g+) activated
phenotype is reflected in altered cell morphology, which is
manifested by an increased vacuolation pattern accompanied
by increased phospholipid and neutral lipid accumulation. The
high content image analysis technique was sufficiently sensitive
to distinguish changes in polarized macrophages. Therefore, this
technique could be implemented in safety assessment
protocols in early in vitro preclinical studies facilitating
decision making in drug discovery. These findings provide a
new insight into foamy alveolar macrophage responses. Studying
the detailed morphological changes within cells has the potential
to determine whether a response is truly adverse or adaptive,
transforming go-no-go decision-making, processes in early in
vitro pre-clinical safety assessment.September 2021 | Volume 12 | Article 611280
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